• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌的组织学变异及其意义。

Histological variants of prostatic carcinoma and their significance.

机构信息

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA.

出版信息

Histopathology. 2012 Jan;60(1):59-74. doi: 10.1111/j.1365-2559.2011.04039.x.

DOI:10.1111/j.1365-2559.2011.04039.x
PMID:22212078
Abstract

The vast majority of prostatic cancers are acinar adenocarcinomas. Histological variants of prostatic carcinoma have been variably defined. One approach is to consider two groups of variants. The first group comprises histological variants of acinar adenocarcinoma and the second group non-acinar carcinoma variants or types. Variants of usual acinar adenocarcinoma defined in 2004 by the World Health Organization (WHO) include atrophic, pseudohyperplastic, foamy, colloid, signet ring, oncocytic and lymphoepithelioma-like carcinomas. The second group of non-acinar carcinoma histological variants or types of prostatic carcinoma accounts for about 5-10% of carcinomas that originate in the prostate. These include sarcomatoid carcinoma, ductal adenocarcinoma, urothelial carcinoma, squamous and adenosquamous carcinoma, basal cell carcinoma, and neuroendocrine tumours, specifically small-cell carcinoma. Recently characterized variants not present in the 2004 WHO classification, including microcystic adenocarcinoma, prostatic intraepithelial neoplasia-like adenocarcinoma, large-cell neuroendocrine carcinoma, and pleomorphic giant cell carcinoma, are also described. The aims of this review are to present the essential histomorphological diagnostic attributes of these variants, and to emphasize the clinical signficance of the variants, when different from usual acinar adenocarcinoma, including clinical presentation and outcome.

摘要

绝大多数前列腺癌为腺泡腺癌。前列腺癌的组织学变异已经有了不同的定义。一种方法是将两种变异类型分开考虑。第一组包括腺泡腺癌的组织学变异,第二组是非腺泡癌变异或类型。2004 年世界卫生组织(WHO)定义的常见腺泡腺癌的变异包括萎缩性、假增生性、泡沫状、胶样、印戒细胞和嗜酸细胞腺癌。前列腺癌的第二组非腺泡癌组织学变异或类型占起源于前列腺的癌的 5-10%左右。这些包括肉瘤样癌、导管腺癌、尿路上皮癌、鳞状细胞癌和腺鳞癌、基底细胞癌和神经内分泌肿瘤,特别是小细胞癌。最近还描述了 2004 年 WHO 分类中没有的特征变异,包括微囊腺癌、前列腺上皮内瘤样腺癌、大细胞神经内分泌癌和多形性巨细胞癌。本综述的目的是介绍这些变异的基本组织形态学诊断特征,并强调当与常见的腺泡腺癌不同时,变异的临床意义,包括临床表现和预后。

相似文献

1
Histological variants of prostatic carcinoma and their significance.前列腺癌的组织学变异及其意义。
Histopathology. 2012 Jan;60(1):59-74. doi: 10.1111/j.1365-2559.2011.04039.x.
2
Histologic classification of prostate cancer.前列腺癌的组织学分类。
Anal Quant Cytopathol Histpathol. 2015 Feb;37(1):39-47.
3
Rare and unusual histological variants of prostatic carcinoma: clinical significance.前列腺癌的罕见及不典型组织学变异型:临床意义
BJU Int. 2008 Nov;102(10):1369-74. doi: 10.1111/j.1464-410X.2008.08074.x. Epub 2008 Sep 12.
4
Histologic variants of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance.前列腺腺癌及其他前列腺癌的组织学变异型:病理标准及临床意义。
Mod Pathol. 1997 Jun;10(6):612-29.
5
Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.前列腺癌的变异和不典型模式:临床病理和鉴别诊断注意事项。
Adv Anat Pathol. 2012 Jul;19(4):204-16. doi: 10.1097/PAP.0b013e31825c6b92.
6
Variants of acinar adenocarcinoma of the prostate mimicking benign conditions.前列腺腺样腺癌的各种变体,类似于良性病变。
Mod Pathol. 2018 Jan;31(S1):S64-70. doi: 10.1038/modpathol.2017.137.
7
Rare histological patterns of prostatic ductal adenocarcinoma.前列腺导管腺癌的罕见组织学类型。
Pathology. 2010 Jun;42(4):319-24. doi: 10.3109/00313021003767314.
8
Histological patterns, subtypes and aspects of prostate cancer: different aspects, different outcomes.前列腺癌的组织学模式、亚型和方面:不同的方面,不同的结果。
Curr Opin Urol. 2022 Nov 1;32(6):643-648. doi: 10.1097/MOU.0000000000001038. Epub 2022 Sep 8.
9
Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.犬基底细胞在前列腺出生后发育、增生诱导、性激素刺激生长中的作用以及癌的导管起源
Prostate. 2001 May 15;47(3):149-63. doi: 10.1002/pros.1058.
10
Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.犬基底细胞在出生后前列腺发育、增生诱导及性激素刺激生长中的作用;以及癌的导管起源
Prostate. 2001 Aug 1;48(3):210-24. doi: 10.1002/pros.1100.

引用本文的文献

1
Secondary Prostate Lymphoma Mimicking Prostate Cancer Successfully Managed by Transurethral Resection to Relieve Urinary Retention.经尿道切除术成功治疗继发性前列腺淋巴瘤并缓解尿潴留,该淋巴瘤酷似前列腺癌。
Pathophysiology. 2025 Aug 2;32(3):38. doi: 10.3390/pathophysiology32030038.
2
Reappraisal of Neuroendocrine Tumor Classification of the Prostate Gland: Translating Molecular Insights into Clinical Practice.前列腺神经内分泌肿瘤分类的重新评估:将分子见解转化为临床实践
Endocr Pathol. 2025 Jul 23;36(1):28. doi: 10.1007/s12022-025-09871-2.
3
Treatment-related pure large-cell neuroendocrine carcinoma of the prostate with systemic metastases in a young adult: a rare case report.
一名年轻成人患有伴有全身转移的与治疗相关的前列腺纯大细胞神经内分泌癌:一例罕见病例报告。
Front Oncol. 2025 Jul 7;15:1617699. doi: 10.3389/fonc.2025.1617699. eCollection 2025.
4
Metastatic Prostate Ductal Adenocarcinoma Presenting as a Solitary Rectal Mucosal Polyp: A Case Report.以孤立性直肠黏膜息肉形式呈现的转移性前列腺导管腺癌:一例报告
Cureus. 2025 Jun 13;17(6):e85962. doi: 10.7759/cureus.85962. eCollection 2025 Jun.
5
A prognostic model for highly aggressive prostate cancer using interpretable machine learning techniques.一种使用可解释机器学习技术的高侵袭性前列腺癌预后模型。
Front Med (Lausanne). 2025 May 12;12:1512870. doi: 10.3389/fmed.2025.1512870. eCollection 2025.
6
Do explainable AI (XAI) methods improve the acceptance of AI in clinical practice? An evaluation of XAI methods on Gleason grading.可解释人工智能(XAI)方法能否提高人工智能在临床实践中的接受度?对XAI方法在 Gleason分级中的评估。
J Pathol Clin Res. 2025 Mar;11(2):e70023. doi: 10.1002/2056-4538.70023.
7
The role of transcription factors in prostate cancer progression.转录因子在前列腺癌进展中的作用。
Mol Cells. 2025 Apr;48(4):100193. doi: 10.1016/j.mocell.2025.100193. Epub 2025 Feb 10.
8
Life expectancy in rare histological prostate cancer subtypes.罕见组织学类型前列腺癌亚型的预期寿命。
Int J Cancer. 2025 Jun 15;156(12):2311-2319. doi: 10.1002/ijc.35323. Epub 2024 Dec 30.
9
Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer.人工智能在前列腺癌的病理诊断、预后及预测中的应用
Am J Clin Exp Urol. 2024 Aug 25;12(4):200-215. doi: 10.62347/JSAE9732. eCollection 2024.
10
Concurrent occurrence of adenocarcinoma and urothelial carcinoma of the prostate gland: A case report.前列腺腺癌与尿路上皮癌同时发生:一例报告。
World J Clin Cases. 2024 Sep 16;12(26):5952-5959. doi: 10.12998/wjcc.v12.i26.5952.